Rare Disease Community Expresses Hope Through Art Genzyme launches second worldwide art program
Without treatment, LSDs are often progressive, can affect multiple systems, and impact quality of life or be life-threatening. There are more than 40 diseases classified as LSDs, rare genetic diseases caused by a deficiency or malfunctioning of a specific enzyme in cell lysosomes. While individually each of these diseases is extremely rare, grouped together they affect one in about every 7,700 babies born. “I am happy to be involved with Expression of Hope because I feel so hopeful and thankful about my future,” said Linda Rubenstein, who has Gaucher disease. “I am pleased to raise awareness of rare diseases and hope it will give others who are first learning of a rare disease the confidence that they too can have a future.” Genzyme also partnered with the Center for Art and Community Partnerships at Massachusetts College of Art and Design (MassArt) in Boston to create art that represented an artist’s individual collaboration with a person living with an LSD. The artists spent hours collaborating by phone and video conference with people living with LSDs to create 14 pieces of art. They shared videos, favorite objects and music so that the artists and subjects could work together to decide how best to capture and express the essence of each person’s unique experience. “My attempt to portray Vanessa’s struggle with Gaucher disease required great understanding and intuition. I hope I was successful and am grateful for this opportunity to take part in such an intimate experience,” said Justine Crosby of MassArt.
“The positive response to the first program from participants around the world was remarkable,” said Jamie Manganello, associate director of patient advocacy at Genzyme. “Our vision is that all those who experience this art will not only be inspired and moved by the powerful expressions of the human spirit that the pieces reveal, but will also have increased awareness of Lysosomal Storage Diseases.” The Expression of Hope exhibit will be permanently housed in a new gallery at Genzyme’s manufacturing facility in Allston, Mass., where the company produces treatments for several LSDs. All of the submitted artwork is featured on the Expression of Hope Web site accompanied by information about the artist. Driven by Expression of Hope’s success, Genzyme has officially begun the Expression of Hope II: Inspiration through Art. To learn how to become involved in the program or to submit artwork, please visit http://www.expressionofhope.com. |
||||||||
|
Terms and Conditions of Use | Privacy Policy | © 2002-2010 Genzyme Corporation. All rights reserved. |